NEW YORK (GenomeWeb News) — GenTel BioSciences today said it has completed a round of financing worth $2 million.
GenTel CEO Alex Vodenlich said in a statement that the funding was “critical” and that the company had raised $500,000 more than initially anticipated.
The company did not discuss how it would spend the cash.
The investment was led by NEW Capital Fund and Wisconsin Investment Partners, both Wisconsin-based investors with an interest in the life sciences industry.